✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Advanced Enzyme Technologies Ltd.

ADVENZYMES

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹3,399 Cr.
P/E
23.06

Advanced Enzyme Technologies Ltd.

  • Advanced Enzyme
  • Fermenta Biotech
  • Concord Biotech
  • TJI Pharma

FAQs on Advanced Enzyme Technologies Ltd. Shareprice

Advanced Enzyme has given lower returns compared to its competitors.
Advanced Enzyme has grown at ~-8.82% over the last 2yrs while peers have grown at a median rate of 12.87%

Advanced Enzyme is not expensive.
Latest PE of Advanced Enzyme is 23.43, while 3 year average PE is 29.66.
Also latest EV/EBITDA of Advanced Enzyme is 15.63 while 3yr average is 18.82.

View FAQ's On Business

Growth Table

  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech

Balance Sheet

  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech

Cash Flow

  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech

Quarterly Results

  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Advanced Enzyme Technologies Ltd. Financials

Balance sheet of Advanced Enzyme is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Advanced Enzyme is increasing.
Latest net debt of Advanced Enzyme is -₹56.78 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹193.74 Crs.

The profit is oscillating.
The profit of Advanced Enzyme is ₹151 Crs for TTM, ₹131 Crs for Mar 2025 and ₹133 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Advanced Enzyme latest dividend payout ratio is 44.37% and 3yr average dividend payout ratio is 32.58%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech